why choose us

First received: February 27, 2023

Clinical Trial: A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986447 in Healthy Participants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Randomized, Double-blind, Placebo-controlled, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single, Ascending Doses of BMS-986447 in He

Brief Summary: The purpose of the study is to evaluate the safety, tolerability and drug levels of single, oral doses of BMS-986447 in healthy participants.

Read more